UK-based femtech startup Elvie has secured £9.6 million in funding. The investment round was backed by existing investors and adds to Elvie’s impressive fundraising history, which includes a £70.7 million Series C round in 2021 and an £18.5 million internal investment in 2022. The company has raised a total of $136 million to date from investors such as BlackRock, Octopus Ventures, and the Business Growth Fund.
Founded in 2013 by Tania Boler, Elvie has been at the forefront of developing products aimed at improving women’s health. Recognizing the lack of support for new mothers, Boler assembled a team of experts to redesign traditional medical devices into sleek, consumer-friendly products that could be used conveniently at home. The company’s goal is to revolutionize categories such as breast pumps and pelvic floor health, addressing critical aspects of women’s wellness often overlooked by traditional healthcare systems.
Elvie’s product portfolio includes four offerings. The Elvie Trainer, the company’s flagship product, is an award-winning Kegel trainer accompanied by an app that helps women strengthen their pelvic floor muscles through engaging workouts with real-time feedback. Another product, the Elvie Pump, is the world’s first silent wearable breast pump, offering women unprecedented freedom and mobility during the pumping process.
In addition to its existing products, Elvie has introduced two new breastfeeding solutions – Elvie Catch and Elvie Curve – which complement its breastfeeding range. Elvie Curve is a wearable silicone breast pump designed for comfort, while Elvie Catch consists of secure milk collection cups to catch leaks and collect additional milk.
